课题基金 / 基金详情

项目摘要

项目成果

John K Spitznagel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human neutrophil polymorphonuclear granulocytes (PMN) are in the first line of cellular defense against infection. They phagocytize bacteria and kill them with antimicrobial activities that are oxygen dependent or oxygen independent. The granules of PMN are intrinsic to these activities. Our goal is to continue to define the proteins that account for antimicrobial activities of crude granule extracts. Our main emphasis will be on anti-Proteus activity and purified cationic antimicrobial proteins (CAP), CAP57 and CAP37 that kill Salmonella and E. coli. We will: define genetic and (tissue) environmental factors contributing to sensitivity or resistance of microorganisms; determine the target molecules CAP interact with in the outer membrane of sensitive bacteria. We will complete studies to localize CAPs at the cellular and subcellular levels. We will use techniques required to understand bacterial pathogenesis and host resistance. We will use: cell culture and differential and gradient centrifugation; phagocytosis; assays for antimicrobial action; protein purification, including conventional and high performance liquid chromatography and affinity chromatography; ELISA; monoclonal antibodies; construction of isogenic strains by P22 transduction; and biochemical analysis of lipopolysaccharides, and outer membrane proteins of Salmonella typhimurium which differ in their resistance to CAP. Our long term objective is to define the role of CAP in oxygen independent antimicrobial phagocytosis and to develop monoclonal antibodies for rapid screening of PMN in clinical infectious disease. The research we propose is significant in that it will: a) establish the existence of at least three highly effective Cationic Antimicrobial Proteins (CAPs) whose mode of action in human PMN is oxygen independent; b) provide biochemical evidence for specific target sites on susceptible bacteria to the action of CAP; c) implicate a contribution of low O2 tension to the resistance to CAPs of N. gonorrhoeae; d) provide highly suggestive evidence for the existence of a heretofore unsuspected antimicrobial granule.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases.
CAP 37 是一种 37 kD 的人中性粒细胞颗粒阳离子蛋白,与炎症蛋白酶具有同源性。
DOI: 10.1016/0024-3205(90)90104-y
发表时间: 1990
期刊: Life sciences
影响因子: 6.1
作者: [Pereira,HA, Spitznagel,JK, Pohl,J, Wilson,DE, Morgan,J, Palings,I, Larrick,JW]
通讯作者: Larrick,JW
Microbial interactions with neutrophils.
微生物与中性粒细胞的相互作用。
DOI: 10.1093/clinids/5.supplement_4.s806
发表时间: 1983
期刊: Reviews of infectious diseases
影响因子: --
作者: [Spitznagel,JK]
通讯作者: Spitznagel,JK
Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.
鼠伤寒沙门氏菌 LT2 的外膜突变体对人类厌氧中性粒细胞的杀菌活性具有脂多糖依赖性抵抗力。
DOI: 10.1128/iai.36.3.1086-1095.1982
发表时间: 1982
期刊: Infection and immunity
影响因子: 3.1
作者: [Okamura,N, Spitznagel,JK]
通讯作者: Spitznagel,JK
Oxygen-independent antimicrobial action in sphingosine-treated neutrophils.
鞘氨醇处理的中性粒细胞中不依赖于氧的抗菌作用。
DOI: 10.1016/0022-1759(89)90363-3
发表时间: 1989
期刊: Journal of immunological methods
影响因子: 2.2
作者: [Stinavage,P, Spitznagel,JK]
通讯作者: Spitznagel,JK
16
    EXPRESSION OF FIMBRIAE IN A ACTINOMYCETEMCOMITANS
    • 批准号:
      2679646
    • 项目类别:
    • 资助金额:
      $11.04万
    • 财政年份:
      1997
    • 负责人:
      John K Spitznagel
    • 依托单位:
    EXPRESSION OF FIMBRIAE IN A ACTINOMYCETEMCOMITANS
    • 批准号:
      2882726
    • 项目类别:
    • 资助金额:
      $9.43万
    • 财政年份:
      1997
    • 负责人:
      John K Spitznagel
    • 依托单位:
    EXPRESSION OF FIMBRIAE IN A ACTINOMYCETEMCOMITANS
    • 批准号:
      6362927
    • 项目类别:
    • 资助金额:
      $9.93万
    • 财政年份:
      1997
    • 负责人:
      John K Spitznagel
    • 依托单位:
    EXPRESSION OF FIMBRIAE IN A ACTINOMYCETEMCOMITANS
    海外基金